中国FAP靶向实体瘤诊断核药首次获FDA快速通道资格认定,远大医药(00512)自研产品直击泛实体瘤千亿美元未满足市场需求
Last Update:
9 8 月, 2026
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.